UNSPSC 51294205: Oxaflozane

This classification denotes an antidepressant agent with the molecular formula C14H18F3NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V4WLW77V5Q, chemically known as 4-isopropyl-2-(alpha,alpha,alpha-trifluoro-m-tolyl)morpholine but generally known as oxaflozane, which bears US NIH Compound Identifier 71915. European Medicines Agency schedules Oxaflozane in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09486MIG.

UNSPSC 51294205 Oxaflozane, a Commodity code, reflects pharmaceutical procurement for emergency medical response and public health support. State and local governments buy naloxone, drug deactivation systems, and related pharmaceutical supplies under this code to support community health initiatives, opioid response programs, and emergency medical services. The issuing bodies include county health departments and public safety agencies procuring through competitive bidding processes with fixed-fee pricing models and multi-year contract terms.

Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The bid response deadline was July 26, 2023, at 2:00 pm, with vendors required to submit electronic bids through the county's e-Procurement Portal, include all shipping and delivery costs in proposals, and comply with drug-free workplace certification and E-Verify requirements. The contract included a two-year initial term with a one-year renewal option and a three-month probationary period. Potential FEMA funding introduced additional compliance obligations under the Clean Air Act and Federal Water Pollution Control Act. No explicit set-aside designations were noted for disadvantaged enterprises.